Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Antihypertensive Treatment and Cardiovascular Risk in Chinese Prehypertensive Population
NCT07652567Completed
- Sponsor
- Qilu Hospital of Shandong University
- Start
- Jan 2007
- Primary completion
- Apr 2026
- Countries
- 1
01
Overview
Randomised trial in prehypertension comparing Placebo, Telmisartan and Indapamide (3 arms). Primary endpoints: Incidence of new-onset hypertension at 4 years, Incidence of new-onset diabetes at 4 years and 1 more. Started Jan 2007; status: completed.
02
Drugs
telmisartanindapamide
03
Conditions
prehypertension
Beyond the preview
Go deeper on NCT07652567.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT07652567.